The Advanced Therapeutics for Alzheimer's Disease Review Board: A multidisciplinary model to facilitate safe access to amyloid-targeting therapies in general neurology across the Sutter Health system.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands) •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Moughamian AJ, La Vallee L, Kile S, et al. (2026). "The Advanced Therapeutics for Alzheimer's Disease Review Board: A multidisciplinary model to facilitate safe access to amyloid-targeting therapies in general neurology across the Sutter Health system.". Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70479